Biogen, Inc. (BIIB)
201.18
+15.82
(+8.53%)
USD |
NASDAQ |
Feb 06, 16:00
197.28
-3.90
(-1.94%)
After-Hours: 20:00
Biogen SG&A Expense (TTM) : 2.434B for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Eli Lilly & Co. | 11.09B |
| Merck & Co., Inc. | 10.73B |
| AbbVie, Inc. | 14.01B |
| Stoke Therapeutics, Inc. | 58.79M |
| Alnylam Pharmaceuticals, Inc. | 1.181B |